Immune RNA in the immunotherapy of cancer.
D000230:Adenocarcinoma / Q000276:immunology; D000818:Animals; D000912:Antibodies, Neoplasm / Q000494:pharmacology; D001943:Breast Neoplasms / Q000276:immunology / Q000628:therapy*; D003601:Cytotoxicity Tests, Immunologic; D003911:Dextrans / Q000031:analogs & derivatives / Q000494:pharmacology; D005260:Female; D006801:Humans; D007167:Immunotherapy; D008213:Lymphocyte Activation / Q000187:drug effects; D008325:Mammary Neoplasms, Experimental / Q000276:immunology / Q000628:therapy; D009362:Neoplasm Metastasis; D009368:Neoplasm Transplantation; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D009374:Neoplasms, Experimental / Q000276:immunology; D012313:RNA / Q000276:immunology / Q000627:therapeutic use*; D051381:Rats; D011916:Rats, Inbred F344; D012260:Ribonucleases / Q000037:antagonists & inhibitors
D000912:Antibodies, Neoplasm; D003911:Dextrans; D012313:RNA; D012260:Ribonucleases